1000616-27-2

Usage

Uses

Used in Pharmaceutical Synthesis:
(4R)-4-hydroxy-D-prolinamide is used as a building block for the synthesis of various pharmaceuticals, leveraging its unique structural properties to create novel compounds with potential therapeutic applications.
Used in Wound Healing and Tissue Regeneration:
(4R)-4-hydroxy-D-prolinamide is studied for its potential therapeutic properties in promoting wound healing and tissue regeneration, capitalizing on its role in collagen biosynthesis to enhance the body's natural repair mechanisms.
Used in Medicinal Chemistry and Biotechnology:
(4R)-4-hydroxy-D-prolinamide is utilized in the field of medicinal chemistry and biotechnology for the development of new drugs and therapies, taking advantage of its unique properties to create innovative solutions for various medical conditions.

Upstream product

• 1499-56-5 (R)-4-hydroxy-L-proline ethyl ester 
• 51-35-4 4R-4-hydroxyproline 
• 13726-69-7 (2S,4R)-4-hydroxy-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-2-carboxylic acid 
• 266337-25-1 (4S)-1-(tert-butoxycarbonyl)-4-hydroxy-L-prolinamide 
• 68172-39-4 benzyl (2S,4R)-4-hydroxypyrrolidine-2-carboxylate 

Relevant academic research and scientific papers

2-Carboxamide Cycloamino Ureas

The present invention relates to compounds of formula I and salts thereof, wherein the substituents are as defined in the description, to compositions and use of the compounds in the treatment of diseases ameloriated by inhibition of phosphatidylinositol

Organic Compounds

The present invention relates to compounds of formula I and its salts, wherein the substituents are as defined in the description, to compositions and use of the compounds in the treatment of diseases ameloriated by inhibition of phosphatidylinositol 3-kinase.

ORGANIC COMPOUNDS

The resent invention relates to a com ound of formula (I) and its salts, wherein the substituents are as defined in the description, to compositions and use of the compounds in the treatment of diseases ameloriated by inhibition of phosphatidylinositol 3-

QUINAZOLINE DERIVATIVES

The invention concerns quinazoline derivatives of Formula (I) wherein each of R1, R3, R20, X1, X2, Z, W, (a) and (q) have any of the meanings defined in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use as an antiproliferative agent in the prevention or treatment of turnours which are sensitive to inhibition of erbB receptor tyrosine kinases, particularly EGFR tyrosine kinase.

Beta-lactam compounds

A beta-lactam compound of the formula: STR1 or a pharmaceutically acceptable salt thereof, which is useful as an anti-microbial agent or an intermediate in the synthesis of anti-microbial agents.